Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BNY).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open: Futures: FTSE (0.14%), DAX +0.24%, CAC40 +0.05%

Jul 24 ,2026

  • Synopsis

    • European indices are set to open mixed as Asia equities trading broadly lower Friday. South Korea selling off sharply again on tracking for weekly declines, weighing on tech-heavy Japan and Taiwan bourses.

    • US equities finished down in Thursday trading, ending a bit above session lows. Major indices on track for weekly declines. Big tech was broadly lower with GOOGL and TSLA the notable Mag 7 decliners on their reports.

    • US confirmed new tariffs of 10-12.5% on some 60 countries over forced labor allegations, effective after midnight Friday ET, effectively replacing the expiring 10% levy. While trading partners debate legitimacy, implications seemingly limited as countries such as Japan anticipate any changes would not over-ride the non-stacking principle stipulated in existing trade deals, and various carveouts in others such as the USMCA. US-China working out details of the Board of Trade framework, while China confirmed they are exploring reciprocal tariff reductions on $30B of goods.

    • In central banks, Russia central bank is expected to lower its benchmark interest rate by 25bps to 14.0% at 12:30CET, publish latest medium-term forecast and hold a press conf at 14:00. ECB releases its latest survey of professional forecasters as well as latest consumer expectations survey results, both at 10:00CET.

    • Macroeconomic releases due today: Eurozone, France, Germany, UK Jul flash manufacturing/services PMI, Germany Aug consumer confidence - GfK, Spain Jun PPI, UK Jul consumer confidence - GfK, Jun retail sales, Sweden Jun PPI, unemployment rate

    • In corporate earnings news early today: CALN.SW , SAB.SM, SGSN.SW, SF.SS, AOF.GR, LIGHT.NA, HOFI.SS, BION.SW, VONN.SW, ALM.SW, MAP.SM, SAP.GR. VOW.GR. SAP.GR, UBI.FP, ENEL.IM.

  • Politics/Macro/World News

    • Trump imposes forced labor duties on 60 trading partners as 10% US tariffs expire (Reuters )

  • Top company news

    • Earnings/updates

      • SAP.GR (SAP) -- reports Q2 non-IFRS EPS €1.59 vs FactSet €1.75 [18 est, €1.67-1.90]

      • UBI.FP (Ubisoft Entertainment) -- reports Q1 revenue €268.2M vs FactSet €261.7M [4 est, €250.6-271M]

      • ENEL.IM (Enel) -- reports Q2 operational data: total installed capacity 92,103 MW vs year-ago 91,033 MW

      • SGSN.SW (SGS) -- reports H1 EPS CHF1.58 ex-items vs consensus CHF1.79; confirms its 2026 outlook

      • CA.FP (Carrefour) -- reports H1 adj. net income €345M vs consensus €302M; confirms FY guidance

      • ALM.SM (Almirall) -- reports H1 normalised net income €42.4M vs FactSet €41.1M [3 est, €38-43.3M]; guides FY26

      • LIGHT.NA (Signify) -- reports Q2 net income €17M vs consensus €24M; confirms FY26 guidance

      • FII.FP (Lisi) -- reports H1 EPS €1.34 vs year-ago €0.83

      • COL.SM (Inmobiliaria Colonial SOCIMI) -- reports H1 EPRA net income €111.4M vs FactSet €109.3M [2 est, €108-110.5M]

      • NOS.PL (NOS SGPS) -- reports Q2 net income €68.4M ex-items vs FactSet €57.2M [2 est, €52.7-61.6M]

      • EXA.FP (Exail Technologies) -- reports Q2 revenue €144M vs FactSet €148.4M [1 est]; confirms FY targets

      • RBT.FP (Robertet) -- reports H1 revenue €444.3M vs FactSet €455.7M [2 est, €448.4-463M]

      • HAVAS.NA (Havas NV) -- reports H1 net income €84M, +14% vs year-ago €74M

      • NXI.FP (Nexity) -- reports H1 Current operating profit €12.0M vs FactSet €15.0M [1 est]

      • VONN.SW (Vontobel Holding) -- reports H1 EPS CHF3.78 vs year-ago CHF2.02

      • NVG.PL (The Navigator Co.) -- reports Q2 net income €31.9M vs FactSet €20M [1 est]

      • ADOC.FP (Adocia) -- reports Q2 revenue €0M vs year-ago €0M

      • ALCGM.FP (Cegedim) -- reports H1 revenue €324.8M vs year-ago €322.5M

      • ALTR.PL (Altri SGPS) -- reports Q2 net income attributable €12.9M vs FactSet €8.4M [3 est, €7-9.5M]

      • GBT.FP (Guerbet) -- reports Q2 revenue €201.7M, (3%) vs year-ago €207.8M

      • ARAMI.FP (Aramis Group) -- reports Q3 revenue €559.2M, (5%) vs year-ago €591.2M

      • VLTSA.FP (Voltalia) -- reports Q2 revenue €198M vs FactSet €163.7M [1 est]

      • 74SW.FP (74Software) -- reports H1 net income €27.4M vs year-ago €5.8M

      • AUB.FP (Aubay) -- reports Q2 revenue €173.6M, +31% vs year-ago €132.8M; raises FY Outlook

      • LIN.FP (Linedata Services) -- reports H1 revenue €82.4M vs FactSet €81.6M [1 est]

      • LNA.FP (LNA Santé) -- reports Q2 revenue €253.0M, +12% vs year-ago €226.4M

    • M&A

      • HSBA.LN (HSBC Holdings) -- to sell HSBC Life (Singapore) to Allianz for SG$2.7B ($2.1B)

      • XPRO (Expro) -- completes acquisition of Enhanced Drilling

      • SAFT (Safety Insurance Group) -- announces agreement to be acquired by Mapfre for $1.54B

      • SAFT (Safety Insurance Group) -- Follow-up: Safety Insurance Group announces agreement to be acquired by Mapfre for $1.54B

      • SYSR.SS (Systemair) -- acquires Temspec; terms not disclosed

    • Healthcare

      • GMAB.DC (Genmab) -- and AbbVie provide clarification on Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab in patients with relapsed/refractory DLBCL

      • IPN.FP (Ipsen) -- Ipsen's Phase III BOLD trial evaluating Bylvay versus placebo for patients living with biliary atresia (BA) who have already undergone a Kasai hepatoportoenterostomy (HPE) did not meet the primary endpoint

      • CVSG.LN (CVS Group) -- Transcript Intelligence: CVS Group Investor Meeting

    • Other

      • TPEIR.GA (Piraeus Bank) -- shares will trade ex the right to share in the previously disclosed €0.40/share capital return on 3-Aug

      • CO.FP (Casino Guichard-Perrachon) -- amends credit terms

      • ALPHA.GA (Alpha Bank SA) -- Alpha Bank to cancel 59.0M own shares

      • FCT.IM (Fincantieri) -- to deliver the fourth submarine to the Italian navy under the U212 NFS (Near Future Submarine) program in 2032 rather than 2034

      • STMPA.FP (STMicroelectronics) -- Street Takeaways - STMicroelectronics Q2 earnings

      • DSV.DC (DSV A/S) -- Street Takeaways - DSV A/S Q2 Earnings

      • AMD announces new products; Cybersecurity, Food segments slip amid weaker Pure Plays in intraday themes (23-Jul)

      • ECB to consider raising banks' minimum reserve requirements - Reuters

      • Rio Tinto signs a 5yr offtake agreement with Superchar to replace coal with bio pellets

  • Key rating changes

    • Upgrades

      • SUS.SS (Surgical Science Sweden) -- to buy from hold at Berenberg

    • Downgrades

      • STAN.LN (Standard Chartered) -- to neutral from buy at UBS

      • 8TRA.SS (TRATON) -- to hold from buy at DNB Carnegie

      • EXA.FP (Exail Technologies) -- to neutral from outperform at Oddo

      • SFSN.SW (SFS Group) -- to neutral from buy at UBS

    • Initiations

      • BPT.LN (Bridgepoint Group) -- buy at Berenberg

  • Data

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE

    • BNY.com Terms of Use Privacy Cookie Notice Manage Cookies Disclaimer CUSIP Disclaimer

    • ©  2025 The Bank of New York Corporation. Depositary Receipt business and services are conducted through The Bank of New York.